threonine has been researched along with Ataxia Telangiectasia Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Augustine, MM; Chen, BPC; Davis, AJ; Laverty, DJ; Lu, H; Nagel, ZD; Puncheon, AC; Williams, GJ; Zhang, Q | 1 |
| Dorie, MJ; Freiberg, RA; Giaccia, AJ; Hammond, EM; Welford, SM | 1 |
| Pietenpol, JA; Stewart, ZA; Tang, LJ | 1 |
3 other study(ies) available for threonine and Ataxia Telangiectasia Syndrome
| Article | Year |
|---|---|
ATM phosphorylates the FATC domain of DNA-PKcs at threonine 4102 to promote non-homologous end joining.
Topics: Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; DNA; DNA End-Joining Repair; DNA Repair; DNA-Activated Protein Kinase; Humans; Threonine | 2023 |
DNA damage during reoxygenation elicits a Chk2-dependent checkpoint response.
Topics: Acetylcysteine; Apoptosis; Ataxia Telangiectasia; Carcinoma; cdc25 Phosphatases; Cell Hypoxia; Cell Survival; Checkpoint Kinase 2; Colorectal Neoplasms; DNA Damage; Free Radical Scavengers; G2 Phase; Humans; Oxygen; Phosphorylation; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Threonine; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2006 |
Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner.
Topics: Antineoplastic Agents; Ataxia Telangiectasia; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; Doxorubicin; Humans; Microtubules; Mutagenesis, Site-Directed; Paclitaxel; Peptide Fragments; Phosphoproteins; Phosphorylation; Protein Isoforms; Protein Serine-Threonine Kinases; Serine; Threonine; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Vincristine | 2001 |